A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
type: MedicalStudy
description: A Phase 1, Open-label, Dose-escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered TG101348 in Patients With Primary, Post-polycythemia Vera, or Post-essential Thrombocythemia Myelofibrosis
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2008-01
end date: 2009-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00631462
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: TargeGen
study subject: Myelofibrosis
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Myelofibrosis

AI Analytics
type: Organization